Oxular Limited
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema (NCT05697809) | Oxular Limited | 2023-08-07 |
| Oxulumis®, Suprachoroidal Drug Administration of Triesence® in Diabetic Macular Edema (NCT05172401) | Oxular Limited | 2022-09-15 |
| Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema (NCT05512962) | Oxular Limited | 2022-08-31 |
Track Oxular Limited automatically
Every clearance here is in the API, with alerts when new ones post.